| |
Date |
| BSD Medical Retains Financial Profiles for Investor Relations |
March 3, 2010 |
 |
| BSD Medical Reports Publication of Chinese Study Using the BSD-2000 Hyperthermia System to Treat Lung Cancer |
February 23, 2010 |
|
| BSD Medical Announces First Swiss Installation of the BSD-2000/3D Hyperthermia System at Kantonsspital Aarau |
February 18, 2010 |
|
| BSD Medical Announces Registered Direct Offering of Common Stock and Warrants in Aggregate Amount of $2 Million |
February 11, 2010 |
|
| BSD Medical Reports Formation of Corporate Governance and Nominating Committee |
February 11, 2010 |
|
| BSD Medical Reports Initiation of a Phase III Study on Pancreatic Cancer Using the BSD-2000 Hyperthermia System in Combination with Chemotherapy |
February 9, 2010 |
|
| BSD Medical Reports Publication of Hyperthermia Article by Journal of the National Cancer Institute |
February 2, 2010 |
|
| BSD Medical Sells Two BSD-2000 Hyperthermia Systems to Chinese Distributor |
January 26, 2010 |
|
| BSD Medical Names Todd Turnlund as Vice President of Engineering |
January 19, 2010 |
|
| BSD Medical Reports German Society of Radiation Oncology Press Release: Addition of Hyperthermia to Standard Therapy is Effective for Treatment of Bladder Cancer |
December 14, 2009 |
|
| BSD Medical Corporation Reports Continuation of FDA Review of BSD-2000 Hyperthermia System |
November 18, 2009 |
|
| BSD Medical Reports Hyperthermia Therapy Contributes to Improved Survival Rate for Bladder Cancer Patients |
October 30, 2009 |
|
| BSD Medical Corporation Sells Hyperthermia System to University of California, San Francisco Medical Center |
September 29, 2009 |
|
| BSD Medical Corporation Files $50 Million Shelf Registration |
September 24, 2009 |
|
| BSD Medical Reports News Briefing at Europe’s Largest Cancer Congress: Hyperthermia and Chemotherapy Treatment Prolongs Survival of Sarcoma Cancer Patients |
September 22, 2009 |
|
| BSD Medical Corporation Reports FDA Review of BSD-2000 Hyperthermia System Continues |
September 18, 2009 |
|
| BSD Medical Hyperthermia System Integrated with GE Healthcare MR System at Duke University School of Medicine |
July 31, 2009 |
|
| Letter to Shareholders. |
July 29, 2009 |
|
| BSD Medical Announces Nationwide Reimbursement in the Netherlands for Cancer Treatment Using Hyperthermia |
June 25, 2009 |
|
| Evolving Role of Clinical Hyperthermia, Including use of BSD Medical Systems, Reviewed at European Society for Hyperthermic Oncology Meeting |
June 12, 2009 |
|
| Timothy McQuay Appointed Chairman of the Board of BSD Medical Corporation |
May 29, 2009 |
|
| BSD Medical Names Steven Smith as Vice President of Marketing and Business Development |
May 27, 2009 |
|
| BSD Receives FDA Humanitarian Use Designation for the BSD-2000 Hyperthermia System |
May 18, 2009 |
|
| Tacoma/Valley Radiation Oncology Centers Provide New Cancer Treatment in Pacific Northwest with Acquisition of BSD-500 Hyperthermia System |
April 23, 2009 |
|
| TV News Coverage Reports on the Use of Hyperthermia to Treat Recurrent Cancers |
April 17, 2009 |
|
| Clinical Study Using Hyperthermia Combined with Chemotherapy to Treat Children and Adolescents Shows Promise |
April 15, 2009 |
|
| Evolving Role of Clinical Hyperthermia Reviewed at Society for Thermal Medicine Annual Meeting |
April 14, 2009 |
|
| BSD Medical Names Harold R. Wolcott as New President and Board Member |
April 7, 2009 |
|
| BSD Medical Corporation: Hyperthermia Therapy Contributes to Improved Tumor Control and Survival Rate for Esophageal Cancer Patients |
March 31, 2009 |
|
| BSD Medical Corp.: Paul F. Turner Receives 2009 Distinguished Alumnus Award from University of Utah |
March 26, 2009 |
|
| BSD Medical Corp.: Lecture at Surgical Oncology Conference Reports Near Doubling of Disease-Free Survival when Hyperthermia Therapy Was Added to Chemotherapy in Treating Sarcoma Cancer Patients |
March 12, 2009 |
|
